|Other Names||Transcription factor SOX-2, SOX2|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP3651a was selected from the region of human Phospho-SOX2-S83. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Transcription factor that forms a trimeric complex with OCT4 on DNA and controls the expression of a number of genes involved in embryonic development such as YES1, FGF4, UTF1 and ZFP206 (By similarity). Critical for early embryogenesis and for embryonic stem cell pluripotency. May function as a switch in neuronal development. Downstream SRRT target that mediates the promotion of neural stem cell self-renewal (By similarity). Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation (By similarity).|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
SOX2 is a member of the SRY-related HMG-box (SOX) family of transcription factors involved in the regulation of embryonic development and in the determination of cell fate. This protein may act as a transcriptional activator after forming a protein complex with other proteins. Mutations in the SOX2 gene have been associated with bilateral anophthalmia, a severe form of structural eye malformation.
Remenyi, A., et al., Genes Dev. 17(16):2048-2059 (2003).Wiebe, M.S., et al., J. Biol. Chem. 278(20):17901-17911 (2003).Fantes, J., et al., Nat. Genet. 33(4):461-463 (2003).Schepers, G.E., et al., Dev. Cell 3(2):167-170 (2002).Kamachi, Y., et al., Trends Genet. 16(4):182-187 (2000).
If you have any additional inquiries please email technical services at firstname.lastname@example.org.